Scannell Timothy J sold NVCR

June 2, 2026 · Form 4 insider transaction

Scannell Timothy J sold 2,945 shares of NovoCure Limited at $15.77 per share, a transaction worth $46.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
2,945
Price
$15.77
Total value
$46.4K
Role
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJune 2, 2026
Filing dateJune 3, 2026
Shares owned after14,288
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.; This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

View the original Form 4 on SEC EDGAR